Some markets are more difficult to gather detailed information from, and the Italian market falls in that category. That means that when we do run analytics on the market, it's important to share! - 1,482 parallel trade

As Pharma Footpath develops its databases, we're able to quickly drill down into the commercial opportunities. Where I think this is most interesting currently is in looking at renegotiated prices in different markets, and taking advantage of these

The Netherlands has been the biggest trading market in Europe that PharmaFootpath had yet to include. I'm pleased to share we've now included the centralised product pricing, national product registrations will follow in the near future.

European countries are increasingly embracing the strategic use of Pharmaceutical Supply Chain Data to create resilient healthcare systems that can meet ongoing challenges. Pharmaceutical Supply Chain Data provides valuable insights into stock levels and enables better decision-making regarding procurement, storage,

The pharma supply chain is an intricate web of processes, regulations, and systems that enable pharmaceutical companies to operate in Europe. Unfortunately, the pharma industry faces numerous challenges which can significantly impact the efficiency and efficacy of pharma supply chains.

The pharmaceutical distribution sector plays a critical role in the European healthcare system. Pharmaceutical wholesalers ensure that medicines move efficiently from manufacturers to pharmacies, hospitals, and healthcare providers across the continent. Europe’s pharmaceutical supply chain relies on a complex